GSK-3 as a therapeutic target of lithium

被引：0
|
作者：
Klein, P. S. [1 ]
机构：
[1] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2006年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S8 / S8
页数：1
相关论文
共 50 条
  • [31] GSK-3 and miRs: Master regulators of therapeutic sensitivity of cancer cells
    Duda, Przemyslaw
    Akula, Shaw M.
    Abrams, Stephen L.
    Steelman, Linda S.
    Gizak, Agnieszka
    Rakus, Dariusz
    McCubrey, James A.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2020, 1867 (10):
  • [32] CDK/GSK-3 inhibitors as therapeutic agents for parenchymal renal diseases
    Obligado, S. H.
    Ibraghimov-Beskrovnaya, O.
    Zuk, A.
    Meijer, L.
    Nelson, P. J.
    KIDNEY INTERNATIONAL, 2008, 73 (06) : 684 - 690
  • [33] GSK-3 as a target for lithium-induced neuroprotection against excitotoxicity in neuronal cultures and animal models of ischemic stroke
    Chuang, De-Maw
    Wang, Zhifei
    Chiu, Chi-Tso
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2011, 4
  • [34] Distinct roles of GSK-3α and GSK-3β phosphorylation in the heart under pressure overload
    Matsuda, Takahisa
    Zhai, Peiyong
    Maejima, Yasuhiro
    Hong, Chull
    Gao, Shumin
    Tian, Bin
    Goto, Kazumichi
    Takagi, Hiromitsu
    Tamamori-Adachi, Mimi
    Kitajima, Shigetaka
    Sadoshima, Junichi
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (52) : 20900 - 20905
  • [35] Lithium and tamoxifend protect the brain of mice against the increase of GSK-3 and the dicrease of phosphorylation of GSK-3 in an animal model of mania amphetamine-induced
    Cechinel Recco, Kelen Cancellier
    Valvassori, Samira da Silva
    Borges, Jessica Lopes
    Varela, Roger B.
    Vitto, Marcelo F.
    da Luz, Gabriele
    Kapczinski, Flavio
    de Souza, Claudio T.
    Quevedo, Joao
    REVISTA BRASILEIRA DE PSIQUIATRIA, 2011, 33 : S36 - S36
  • [36] GSK3: A Novel Therapeutic Target in NETs?
    Weis, C.
    Prada, Aristizabal E. T.
    Maurer, J.
    Spoettl, G.
    Grossman, A.
    Auernhammer, C. J.
    Noelting, S.
    NEUROENDOCRINOLOGY, 2017, 105 : 227 - 227
  • [37] GSK-3α Is a Novel Target of CREB and CREB-GSK-3α Signaling Participates in Cell Viability in Lung Cancer
    Park, Sin-Aye
    Lee, Jong Woo
    Herbst, Roy S.
    Koo, Ja Seok
    PLOS ONE, 2016, 11 (04):
  • [38] Glycogen synthase kinase-3 (GSK-3): A kinase with exceptional therapeutic potential
    Benbow, JW
    Helal, CJ
    Kung, DW
    Wager, TT
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 40, 2005, 40 : 135 - 147
  • [39] GSK-3 is a novel target of CREB and GSK-3-CREB signaling participates in cell survival in lung cancer
    Park, Sin-Aye
    Lee, Jong Woo
    Herbst, Roy S.
    Koo, Jaseok Peter
    CANCER RESEARCH, 2015, 75
  • [40] GSK-3 activity in neocortical cells is inhibited by lithium but not carbamazepine or valproic acid
    Ryves, WJ
    Dalton, EC
    Harwood, AJ
    Williams, RSB
    BIPOLAR DISORDERS, 2005, 7 (03) : 260 - 265
12345